240 related articles for article (PubMed ID: 24548237)
41. The effect of RAFT-derived cationic block copolymer structure on gene silencing efficiency.
Hinton TM; Guerrero-Sanchez C; Graham JE; Le T; Muir BW; Shi S; Tizard ML; Gunatillake PA; McLean KM; Thang SH
Biomaterials; 2012 Oct; 33(30):7631-42. PubMed ID: 22831854
[TBL] [Abstract][Full Text] [Related]
42. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
Zhu C; Jung S; Luo S; Meng F; Zhu X; Park TG; Zhong Z
Biomaterials; 2010 Mar; 31(8):2408-16. PubMed ID: 19963269
[TBL] [Abstract][Full Text] [Related]
43. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH
J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950
[TBL] [Abstract][Full Text] [Related]
44. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
Liu CW; Lin WJ
J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
[TBL] [Abstract][Full Text] [Related]
45. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation.
Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW
J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of poly(meth)acrylates with thioether and tertiary sulfonium groups by ARGET ATRP and their use as siRNA delivery agents.
Mackenzie MC; Shrivats AR; Konkolewicz D; Averick SE; McDermott MC; Hollinger JO; Matyjaszewski K
Biomacromolecules; 2015 Jan; 16(1):236-45. PubMed ID: 25515324
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery.
Cavallaro G; Licciardi M; Amato G; Sardo C; Giammona G; Farra R; Dapas B; Grassi M; Grassi G
Int J Pharm; 2014 May; 466(1-2):246-57. PubMed ID: 24631053
[TBL] [Abstract][Full Text] [Related]
48. Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages.
Ortega RA; Barham WJ; Kumar B; Tikhomirov O; McFadden ID; Yull FE; Giorgio TD
Nanoscale; 2015 Jan; 7(2):500-10. PubMed ID: 25408159
[TBL] [Abstract][Full Text] [Related]
49. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
Andersen MØ; Howard KA; Kjems J
Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
[TBL] [Abstract][Full Text] [Related]
50. Systemic siRNA delivery to a spontaneous pancreatic tumor model in transgenic mice by PEGylated calcium phosphate hybrid micelles.
Pittella F; Cabral H; Maeda Y; Mi P; Watanabe S; Takemoto H; Kim HJ; Nishiyama N; Miyata K; Kataoka K
J Control Release; 2014 Mar; 178():18-24. PubMed ID: 24440662
[TBL] [Abstract][Full Text] [Related]
51. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
Ohno K; Mori C; Akashi T; Yoshida S; Tago Y; Tsujii Y; Tabata Y
Biomacromolecules; 2013 Oct; 14(10):3453-62. PubMed ID: 23957585
[TBL] [Abstract][Full Text] [Related]
52. Surface engineering of gold nanoparticles for in vitro siRNA delivery.
Zhao E; Zhao Z; Wang J; Yang C; Chen C; Gao L; Feng Q; Hou W; Gao M; Zhang Q
Nanoscale; 2012 Aug; 4(16):5102-9. PubMed ID: 22782309
[TBL] [Abstract][Full Text] [Related]
53. Magnetic pH-responsive nanogels as multifunctional delivery tools for small interfering RNA (siRNA) molecules and iron oxide nanoparticles (IONPs).
Curcio A; Marotta R; Riedinger A; Palumberi D; Falqui A; Pellegrino T
Chem Commun (Camb); 2012 Feb; 48(18):2400-2. PubMed ID: 22266784
[TBL] [Abstract][Full Text] [Related]
54. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
55. Nanoparticulate nonviral agent for the effective delivery of pDNA and siRNA to differentiated cells and primary human T lymphocytes.
Schallon A; Synatschke CV; Jérôme V; Müller AH; Freitag R
Biomacromolecules; 2012 Nov; 13(11):3463-74. PubMed ID: 23020076
[TBL] [Abstract][Full Text] [Related]
56. Star polymers with a cationic core prepared by ATRP for cellular nucleic acids delivery.
Cho HY; Averick SE; Paredes E; Wegner K; Averick A; Jurga S; Das SR; Matyjaszewski K
Biomacromolecules; 2013 May; 14(5):1262-7. PubMed ID: 23560989
[TBL] [Abstract][Full Text] [Related]
57. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
Wang XL; Xu R; Lu ZR
J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
[TBL] [Abstract][Full Text] [Related]
58. Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery.
Wang X; Yu B; Wu Y; Lee RJ; Lee LJ
Anticancer Res; 2011 May; 31(5):1619-26. PubMed ID: 21617218
[TBL] [Abstract][Full Text] [Related]
59. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
[TBL] [Abstract][Full Text] [Related]
60. Doxorubicin-loaded nanosized micelles of a star-shaped poly(ε-caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer.
Cuong NV; Hsieh MF; Chen YT; Liau I
J Biomater Sci Polym Ed; 2011; 22(11):1409-26. PubMed ID: 20594418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]